AI assistant
ELDERS LIMITED — Director's Dealing 2023
Jan 5, 2023
64835_rns_2023-01-05_23d837a1-c48e-408b-a7ef-62407cea4fe9.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Elders Limited ABN 34 004 336 636
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Mark Charles Allison |
|---|---|
| Date of last notice | 25 November 2022 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | i) Direct ii) Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
i) Direct – held by Mark Charles Allison ii) Indirect – held by Certane Ct Pty Ltd |
| Date of change | 30 December 2022 |
| No. of securities held prior to change | i) a. 203,400 unvested performance rights b. 1,152,124 ordinary fully paid shares ii) 16,726 ordinary fully paid shares |
| Class | i) a. unvested performance rights b. ordinary fully paid shares ii) ordinary fully paid shares |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | i) a. 107,000 unvested performance rights b. nil ii) 28,164 ordinary fully paid shares |
|---|---|
| Number disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
i) a. nil b. nil ii) $11.887 per share (calculated on the 5- day VWAPto 30 September 2022) |
| No. of securities held after change | i) a. 310,400 unvested performance rights b. 1,152,124 ordinary fully paid shares ii) 44,890 ordinary fully paid shares |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy- back |
i) a. Issue of unquoted performance rights under Elders’ Long-Term Incentive Plan, as approved by Shareholders on 15 December 2022. b. N/A ii) shares allocated pursuant to the Elders’ FY22 Short-Term Incentive Plan. Shares to satisfy the allocation were purchased on-market. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder (if issued securities) |
N/A |
| Date of change | N/A |
| No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed |
N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
| Interest acquired | N/A |
|---|---|
| Interest disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation |
N/A |
| Interest after change | N/A |
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 3